3530 TORINGDON WAY # 200 CHARLOTTE, NC 28277 Get Directions
3530 TORINGDON WAY # 200 CHARLOTTE, NC 28277 Get Directions
Company Overview
Chelsea Therapeutics is committed to providing new medications that will improve patients' quality of life.
Chelsea Therapeutics is a biopharmaceutical company that acquires and develops innovative products for the treatment of a variety of human diseases, including central nervous system disorders.
Chelsea acquired the global development and commercialization rights to droxidopa in 2006 from Dainippon Sumitomo Pharma Co., Ltd., excluding Japan, Korea, China and Taiwan.
In addition to droxidopa, we have a portfolio of metabolically inert antifolates that we have studied as potential treatments for rheumatoid arthritis. They also may be suitable for the treatment of multiple other autoimmune disorders.
© Dun & Bradstreet, Inc. 2024. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.